Stability Testing. (a) KRYPTON shall be responsible for and perform or have performed at its own cost, the stability testing of the Final Product according to the then current requirements of the FDA in bulk packaging and in the final packaging materials. GENTA JAGO shall have no liability or responsibility whatsoever with respect to such stability testing, including without limitation, the performance or conduct of such stability testing or the availability or quality of the results and data from such stability testing to be carried out or requested by KRYPTON. (b) KRYPTON shall provide to GENTA JAGO with a copy of all stability testing data within thirty (30) days after the completion of each stability testing period (hereinafter referred to as the "Final Stability Testing Report") for GENTA JAGO's file. (c) GENTA JAGO agrees to provide additional technical assistance and consultation as may be reasonably requested by KRYPTON in connection with the stability testing of the Final Product. KRYPTON shall pay to GENTA JAGO for such services provided by GENTA JAGO's or Jago Pharma's personnel an amount of USD * or part thereof spent, and furthermore, KRYPTON shall reimburse GENTA JAGO for all reasonable and documented travel related expenses of GENTA JAGO personnel who travel at KRYPTON's request to locations remote from such personnel's usual working location.
Appears in 3 contracts
Sources: Development & Sub License Agreement (Genta Incorporated /De/), Option, Development & Sub License Agreement (Genta Incorporated /De/), Development & Sub License Agreement (Genta Incorporated /De/)